Fiche centre
Karolinska University Hospital Solna
Stockholm — Sweden
Essais liés3clinical trials
VilleStockholmlocalisation
PaysSwedenlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03934372
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Alemtuzumab | SEP | Phase 2 | NCT01361711 | Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia | ACTIVE_NOT_RECRUITING |
| Ponatinib | Cancer | Phase 1/2 | NCT03934372 | Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors | RECRUITING |
| Immunostimulating Interstitial Laser Thermotherapy | Cancer | Non applicable | NCT02650492 | Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma | TERMINATED |